Plasma concentrations of steroid precursors, steroids, neuroactive steroids, and neurosteroids in healthy neonatal foals from birth to 7 days of age.


Journal

Journal of veterinary internal medicine
ISSN: 1939-1676
Titre abrégé: J Vet Intern Med
Pays: United States
ID NLM: 8708660

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 28 05 2019
accepted: 26 08 2019
pubmed: 7 9 2019
medline: 6 2 2020
entrez: 7 9 2019
Statut: ppublish

Résumé

Transient hypothalamic-pituitary-adrenal axis dysfunction occurs in critically ill foals with sepsis and neonatal maladjustment syndrome (NMS). Cortisol is the most commonly measured steroid. However, a complex interaction of various steroid compounds might play a role in pathophysiology of this disorder. To identify steroid compounds present at high concentrations at birth that rapidly and steadily decrease within the first 7 days of life in healthy foals and that might be supportive diagnosis of NMS and other neonatal disorders. Ten healthy neonatal Quarter Horse foals (5 females and 5 males). Prospective study. Blood was collected in heparinized tubes within 30 minutes after birth, and at 12, 24, 48, 72, 96, 120, 144, and 168 hours of age. Plasma was separated and a panel of steroid compounds was analyzed using liquid chromatography-mass spectrometry. A nonlinear regression model was used to determine decay concentrations over time. Confidence intervals (CIs) were calculated and significance was set a P ≤ .05. Five compounds were identified: pregnenolone, progesterone, deoxycorticosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate. Pregnenolone and progesterone concentrations rapidly decreased by 24 hours of age and remained low throughout the first 7 days of life. Their half-life (95% CI) was short at 3.7 (3.4, 4.0) and 4.5 (2.8, 6.1) hours, respectively. No statistical differences in the concentrations of these compounds were found between males and females. Progesterone might be a useful marker for identifying continuous endogenous production of neuroactive steroids in foals with suspected NMS and other neonatal diseases.

Sections du résumé

BACKGROUND BACKGROUND
Transient hypothalamic-pituitary-adrenal axis dysfunction occurs in critically ill foals with sepsis and neonatal maladjustment syndrome (NMS). Cortisol is the most commonly measured steroid. However, a complex interaction of various steroid compounds might play a role in pathophysiology of this disorder.
OBJECTIVE OBJECTIVE
To identify steroid compounds present at high concentrations at birth that rapidly and steadily decrease within the first 7 days of life in healthy foals and that might be supportive diagnosis of NMS and other neonatal disorders.
ANIMALS METHODS
Ten healthy neonatal Quarter Horse foals (5 females and 5 males).
METHODS METHODS
Prospective study. Blood was collected in heparinized tubes within 30 minutes after birth, and at 12, 24, 48, 72, 96, 120, 144, and 168 hours of age. Plasma was separated and a panel of steroid compounds was analyzed using liquid chromatography-mass spectrometry. A nonlinear regression model was used to determine decay concentrations over time. Confidence intervals (CIs) were calculated and significance was set a P ≤ .05.
RESULTS RESULTS
Five compounds were identified: pregnenolone, progesterone, deoxycorticosterone, dehydroepiandrosterone, and dehydroepiandrosterone sulfate. Pregnenolone and progesterone concentrations rapidly decreased by 24 hours of age and remained low throughout the first 7 days of life. Their half-life (95% CI) was short at 3.7 (3.4, 4.0) and 4.5 (2.8, 6.1) hours, respectively. No statistical differences in the concentrations of these compounds were found between males and females.
CONCLUSIONS AND CLINICAL RELEVANCE CONCLUSIONS
Progesterone might be a useful marker for identifying continuous endogenous production of neuroactive steroids in foals with suspected NMS and other neonatal diseases.

Identifiants

pubmed: 31489708
doi: 10.1111/jvim.15618
pmc: PMC6766486
doi:

Substances chimiques

Desoxycorticosterone 40GP35YQ49
Dehydroepiandrosterone 459AG36T1B
Progesterone 4G7DS2Q64Y
Dehydroepiandrosterone Sulfate 57B09Q7FJR
Pregnenolone 73R90F7MQ8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2286-2293

Informations de copyright

© 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.

Références

Reprod Fertil Dev. 1995;7(3):567-75
pubmed: 8606970
J Vet Intern Med. 2018 May;32(3):1185-1193
pubmed: 29582480
J Vet Intern Med. 2011 Mar-Apr;25(2):345-55
pubmed: 21281351
J Vet Intern Med. 2012 May-Jun;26(3):654-61
pubmed: 22443385
J Reprod Fertil Suppl. 1991;44:609-17
pubmed: 1795303
J Vet Intern Med. 2009 Jul-Aug;23(4):901-12
pubmed: 19496914
J Vet Intern Med. 2013 Mar-Apr;27(2):331-8
pubmed: 23398197
Pediatr Res. 2009 Mar;65(3):255-60
pubmed: 19092726
Psychoneuroendocrinology. 1998 Nov;23(8):963-87
pubmed: 9924747
Br J Anaesth. 1973 Mar;45(3):237-43
pubmed: 4572998
J Chromatogr A. 2008 May 2;1189(1-2):426-34
pubmed: 18054785
Eur Neuropsychopharmacol. 2007 Feb;17(3):157-64
pubmed: 17079119
Pediatric Health Med Ther. 2015 Mar 18;6:15-32
pubmed: 29388613
Pediatr Res. 2002 Dec;52(6):892-9
pubmed: 12438667
Exp Biol Med (Maywood). 2016 Jun;241(12):1343-50
pubmed: 27302177
J Reprod Fertil Suppl. 1991;44:579-90
pubmed: 1665519
Reproduction. 2017 Oct;154(4):445-454
pubmed: 28878092
Equine Vet J Suppl. 2012 Feb;(41):109-12
pubmed: 22594038
Ann N Y Acad Sci. 1995 Dec 29;771:257-72
pubmed: 8597405
Can Med Assoc J. 1940 Feb;42(2):113-6
pubmed: 20321603
J Reprod Fertil Suppl. 1982;32:507-10
pubmed: 6962891
Equine Vet J. 1984 Jul;16(4):300-2
pubmed: 6090120
Equine Vet J. 2017 Mar;49(2):207-210
pubmed: 26728952
Equine Vet J. 2013 Nov;45(6):661-5
pubmed: 23600660
J Vet Intern Med. 2019 Sep;33(5):2286-2293
pubmed: 31489708
Vet Clin North Am Equine Pract. 2011 Apr;27(1):19-34
pubmed: 21392651
Equine Vet J Suppl. 1997 Jun;(24):96-9
pubmed: 9355809
Am J Vet Res. 2012 Dec;73(12):1881-9
pubmed: 23176413
J Pharmacol Exp Ther. 2004 Jul;310(1):230-9
pubmed: 14982969
J Neurosci. 2011 Jan 12;31(2):650-8
pubmed: 21228174
J Vet Intern Med. 2009 Mar-Apr;23(2):344-51
pubmed: 19192152
Trends Pharmacol Sci. 2016 Jul;37(7):543-561
pubmed: 27156439
Front Endocrinol (Lausanne). 2011 Oct 05;2:38
pubmed: 22654805
J Neurosci. 2009 May 20;29(20):6449-60
pubmed: 19458216
J Reprod Fertil Suppl. 1975 Oct;(23):865-90
pubmed: 1107546
Front Cell Neurosci. 2013 Jul 31;7:115
pubmed: 23914154
Adv Biochem Psychopharmacol. 1992;47:87-92
pubmed: 1354922
J Vet Intern Med. 2007 Jul-Aug;21(4):791-6
pubmed: 17708401
Equine Vet J. 1972 Jul;4(3):117-28
pubmed: 4568905
FASEB J. 1992 Mar;6(6):2311-22
pubmed: 1347506
J Perinatol. 2017 May;37(5):591-595
pubmed: 28102853
Acta Vet Hung. 1998;46(4):501-13
pubmed: 9713151
Brain Res. 2010 Dec 10;1364:198-215
pubmed: 20869351
Eur J Neurosci. 1998 Sep;10(9):2905-12
pubmed: 9758160
Equine Vet J. 2017 Jan;49(1):45-50
pubmed: 26538009
Can Vet J. 2007 Aug;48(8):823-6
pubmed: 17824324
Equine Vet J. 2013 Nov;45(6):656-60
pubmed: 24117932
Equine Vet J Suppl. 1988 Sep;(5):41-3
pubmed: 9118085
Theriogenology. 2018 Dec;122:130-136
pubmed: 30265893
Equine Vet J. 1984 Jul;16(4):278-86
pubmed: 6090119
Anesthesiology. 1975 Mar;42(3):331-44
pubmed: 236704
Vet J. 2017 Jul;225:42-49
pubmed: 28720298
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13284-9
pubmed: 9789080
Intensive Care Med. 2017 Dec;43(12):1781-1792
pubmed: 28940017
Stress. 2011 Jan;14(1):6-12
pubmed: 20666638
J Reprod Fertil Suppl. 1991;44:517-28
pubmed: 1795295
Theriogenology. 2019 Jan 1;123:139-144
pubmed: 30308389
Chest. 2002 Nov;122(5):1784-96
pubmed: 12426284
Front Endocrinol (Lausanne). 2011 Oct 04;2:44
pubmed: 22654809
Science. 1941 Jul 25;94(2430):94
pubmed: 17774030
Trends Pharmacol Sci. 1991 Apr;12(4):141-7
pubmed: 2063480
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):169-92
pubmed: 15694225

Auteurs

Monica Aleman (M)

Medicine and Epidemiology, University of California, Davis, Davis, California.

Patrick M McCue (PM)

Clinical Sciences, Colorado State University, Fort Collins, Colorado.

Munashe Chigerwe (M)

Medicine and Epidemiology, University of California, Davis, Davis, California.

John E Madigan (JE)

Medicine and Epidemiology, University of California, Davis, Davis, California.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH